129 related articles for article (PubMed ID: 18053198)
21. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
22. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
Van Wely M; Westergaard LG; Bossuyt PM; Van der Veen F
Cochrane Database Syst Rev; 2003; (1):CD003973. PubMed ID: 12535497
[TBL] [Abstract][Full Text] [Related]
23. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
Tsai HD; Chen CM; Lo HY; Chang CC
Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
[TBL] [Abstract][Full Text] [Related]
24. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
26. Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program.
Grochowski D; Wołczyński S; Kuczyński W; Domitrz J; Szamatowicz J; Szamatowicz M
Gynecol Endocrinol; 1999 Oct; 13(5):297-304. PubMed ID: 10599545
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study.
El-Nemr A; Bhide M; Khalifa Y; Al-Mizyen E; Gillott C; Lower AM; Al-Shawaf T; Grudzinskas JG
Eur J Obstet Gynecol Reprod Biol; 2002 Jul; 103(2):140-5. PubMed ID: 12069736
[TBL] [Abstract][Full Text] [Related]
28. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
29. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
30. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
31. Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial.
Saunders H; Khan C; D'Hooghe T; Magnúsdóttir TB; Klingmann I; Hrafnsdóttir S;
Hum Reprod; 2020 Feb; 35(2):355-363. PubMed ID: 32074281
[TBL] [Abstract][Full Text] [Related]
32. Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles.
Platteau P; Nyboe Andersen A; Loft A; Smitz J; Danglas P; Devroey P
Reprod Biomed Online; 2008 Aug; 17(2):190-8. PubMed ID: 18681992
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Different Progestins in Women With Advanced Endometriosis Undergoing Controlled Ovarian Hyperstimulation for
Guo H; Li J; Shen X; Cong Y; Wang Y; Wu L; Li B; Gao H; Ma M; Zhang W; Mao X; Fu Y; Lyu Q; Chai W; Kuang Y
Front Endocrinol (Lausanne); 2020; 11():129. PubMed ID: 32265834
[No Abstract] [Full Text] [Related]
34. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
[TBL] [Abstract][Full Text] [Related]
35. Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction.
Souza PMG; Carvalho BR; Nakagawa HM; Rassi TRE; Barbosa ACP; Silva AA
JBRA Assist Reprod; 2017 Jun; 21(2):67-69. PubMed ID: 28609269
[TBL] [Abstract][Full Text] [Related]
36. Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study.
Qiu Q; Huang J; Li Y; Chen X; Lin H; Li L; Yang D; Wang W; Zhang Q
Hum Reprod; 2020 Jun; 35(6):1411-1420. PubMed ID: 32383771
[TBL] [Abstract][Full Text] [Related]
37. A randomized controlled trial comparing the efficacy and safety of two HMG preparations gaining their LH bioactivity from different HCG sources.
Lockwood G; Cometti B; Bogstad J; Erb K; De Geyter C; Urbancsek J; Trevisan S; Pocate-Cheriet K; de Ziegler D
Reprod Biomed Online; 2017 Jul; 35(1):17-27. PubMed ID: 28476487
[TBL] [Abstract][Full Text] [Related]
38. Subcutaneously administered Repronex in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment.
Nichols J; Knochenhauer E; Fein SH; Nardi RV; Marshall DC
Fertil Steril; 2001 Jul; 76(1):58-66. PubMed ID: 11438320
[TBL] [Abstract][Full Text] [Related]
39. A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients.
Qiao J; Zhang Y; Liang X; Ho T; Huang HY; Kim SH; Goethberg M; Mannaerts B; Arce JC
Hum Reprod; 2021 Aug; 36(9):2452-2462. PubMed ID: 34179971
[TBL] [Abstract][Full Text] [Related]
40. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
